In the above-mentioned paper, the expression of PPAR*γ* was incorrectly determined based on the quantification of a 50 kD band on the Western blots. This band aligned with what was believed to be a positive control band in the U937 whole cell extract, a control reagent recommended by the supplier of the primary antibody, SC-7196 (Santa Cruz Biotechnologies, Santa Cruz, CA). Based on recent information described by Foreman et al. \[[@B1]\], it is clear that this band is not PPAR*γ* but was a nonspecific immunoreactive protein detected by SC-7196. This nonspecific protein was abundantly detected by SC-7196 in U937 and COS-1 cells as well as across all human fetal protein samples. Immunoprecipitation of COS-1 cell lysate using agarose-conjugated SC-7196 resulted in a single band on a Coomassie Blue-stained gel. This band was subjected to digestion, peptide extraction, and sequence analysis using MALDI-MSMS, and the protein was identified as cytoplasmic actin with a decisive score (human SwissProt database, 60% protein coverage using the 15 highest scoring peptide groups and two lower scoring but acceptable peptides).

A specific band for PPAR*γ*, (calculated molecular weight for human PPAR*γ*1 = 54.55 kD) was identified on our Western blots by performing new experiments in which in vitro translated human PPAR*γ*1 (provided by J. Peters, Pennsylvania State University) was compared with human fetal tissue lysates ([Figure 1](#fig1){ref-type="fig"}). These experiments also included COS-1 cell lysate as a negative control and U937 cell lysate. The Western blots of the fetal tissues were all reanalyzed using the \~55 kD band that aligned with the in vitro translated human PPAR*γ*1. Based on this reanalysis, the expression of PPAR*γ* protein shown in (c) of Figures  1--9 are replaced by [Figure 2](#fig2){ref-type="fig"}. The data summary described in Table  1 of the above-mentioned paper regarding the change in PPAR*γ* protein expression with fetal age is replaced by [Table 1](#tab1){ref-type="table"}.

The authors regret this unexpected error. The clarification of the recognition patterns of this primary antibody should be of value to investigators interested in detecting PPAR*γ* protein.

![Western blot showing the comparison of banding patterns in COS-1 cell lysate, U937 cell lysate, in vitro translated human PPAR*γ*1, and tissue lysate from human fetal stomach samples. The \~55 kD band of human PPAR*γ*1 and corresponding band in stomach tissue lysate is marked with an asterisk (∗). The nonspecific, cytoplasmic actin band is marked with an arrow.](PPAR2010-627284.001){#fig1}

![PPAR*γ* protein expression is shown across the fetal age range for each tissue. Western blot density normalized to glyceraldehyde-3-phophate dehydrogenase (GAPDH). If only one sample was available for a particular age, then an error term could not be calculated and no SEM bar is shown. Regression analysis evaluated change with age. Dashed lines are the 95% confidence interval.](PPAR2010-627284.002){#fig2}

  Tissue      Protein change with age   
  ----------- ------------------------- -------------
  Thymus      NS                        
  Intestine   Increase                  *P* \< .01
  Spleen      Decrease                  *P* \< .001
  Liver       Increase                  *P* \< .05
  Kidney      Decrease                  *P* \< .05
  Lung        Decrease                  *P* \< .001
  Stomach     NS                        
  Heart       Decrease                  *P* \< .05
  Adrenal     Decrease                  *P* \< .05

NS = no significant change with age.
